Table VII.
Studies, n | 2 |
Reconstructions, n | 30 |
Metastatic disease, n (%) | 8 (27) |
Primary malignancy, n (%) | 22 (73) |
Mean age in yrs, n (range) | 58 (22 to 80) |
Male patients, n (%) | 6 (60) |
Mean follow-up in yrs, n (range) | 4.7 (0.7 to 9.4) |
Harris Hip Score at final follow-up | 74 |
Patient mortality | |
AWD, n (%) | 21 (70) |
DOD, n (%) | 1 (3) |
Implant survivorship from all-cause revision at final follow-up, % | 100 |
Complications, n (%) | |
Dislocation | 4 (13) |
Superficial Infection | 2 (7) |
Thrombotic complication | 2 (7) |
Bleeding complication | 2 (7) |
Wound healing | 1 (3) |
AWD, alive with disease; DOD, dead of disease